Easytech Reversed Shoulder System Clinical Study
Pivotal, Non-Randomized, Historically Controlled, Prospective, Multi-Center Clinical Study of the Easytech Reversed Shoulder System
Sponsor: FX Shoulder Solutions
A NA clinical study on Avascular Necrosis of the Head of Humerus and Osteo Arthritis Shoulders, this trial is ongoing. The trial is conducted by FX Shoulder Solutions and has accumulated 10 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Nov 2025 — Present [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Nov 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Oct 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Jul 2022 — Oct 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Jun 2021 — Jul 2022 [monthly]
Recruiting NA
-
Jan 2021 — Jun 2021 [monthly]
Recruiting NA
-
Mar 2020 — Jan 2021 [monthly]
Recruiting NA
-
Feb 2020 — Mar 2020 [monthly]
Recruiting NA
-
Feb 2019 — Feb 2020 [monthly]
Recruiting NA
First recorded
Nov 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- FX Shoulder Solutions
For direct contact, visit the study record on ClinicalTrials.gov .